vs
Axogen, Inc.（AXGN）与REGIS CORP（RGS）财务数据对比。点击上方公司名可切换其他公司
Axogen, Inc.的季度营收约是REGIS CORP的1.1倍（$61.5M vs $57.1M），REGIS CORP净利率更高（0.8% vs -31.9%，领先32.7%），Axogen, Inc.同比增速更快（26.6% vs 22.3%），REGIS CORP自由现金流更多（$891.0K vs $-1.4M），过去两年Axogen, Inc.的营收复合增速更高（13.3% vs 7.8%）
Axogen总部位于美国佛罗里达州阿拉楚阿，是外科解决方案提供商，专注开发周围神经损伤修复相关产品，涵盖人体组织移植物、神经连接器、软组织膜等，旗下AVANCE细胞移植技术可模拟人体神经结构，临床数据显示其产品帮助87%的周围神经损伤患者实现感觉与运动功能恢复，2013年完成1800万美元首次公开募股。
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
AXGN vs RGS — 直观对比
营收规模更大
AXGN
是对方的1.1倍
$57.1M
营收增速更快
AXGN
高出4.3%
22.3%
净利率更高
RGS
高出32.7%
-31.9%
自由现金流更多
RGS
多$2.3M
$-1.4M
两年增速更快
AXGN
近两年复合增速
7.8%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $61.5M | $57.1M |
| 净利润 | $-19.6M | $456.0K |
| 毛利率 | 75.2% | — |
| 营业利润率 | 20.2% | 10.8% |
| 净利率 | -31.9% | 0.8% |
| 营收同比 | 26.6% | 22.3% |
| 净利润同比 | -410.8% | -94.0% |
| 每股收益（稀释后） | $-0.38 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXGNRGS
| Q1 26 | $61.5M | — | ||
| Q4 25 | $59.9M | $57.1M | ||
| Q3 25 | $60.1M | $59.0M | ||
| Q2 25 | $56.7M | $60.4M | ||
| Q1 25 | $48.6M | $57.0M | ||
| Q4 24 | $49.4M | $46.7M | ||
| Q3 24 | $48.6M | $46.1M | ||
| Q2 24 | $47.9M | $49.4M |
净利润AXGNRGS
| Q1 26 | $-19.6M | — | ||
| Q4 25 | $-13.2M | $456.0K | ||
| Q3 25 | $708.0K | $1.4M | ||
| Q2 25 | $579.0K | $116.5M | ||
| Q1 25 | $-3.8M | $250.0K | ||
| Q4 24 | $450.0K | $7.6M | ||
| Q3 24 | $-1.9M | $-853.0K | ||
| Q2 24 | $-1.9M | $91.2M |
毛利率AXGNRGS
| Q1 26 | 75.2% | — | ||
| Q4 25 | 74.1% | — | ||
| Q3 25 | 76.6% | — | ||
| Q2 25 | 74.2% | — | ||
| Q1 25 | 71.9% | — | ||
| Q4 24 | 76.1% | — | ||
| Q3 24 | 74.9% | — | ||
| Q2 24 | 73.8% | — |
营业利润率AXGNRGS
| Q1 26 | 20.2% | — | ||
| Q4 25 | -16.3% | 10.8% | ||
| Q3 25 | 3.2% | 10.0% | ||
| Q2 25 | 3.0% | 12.1% | ||
| Q1 25 | -3.4% | 8.8% | ||
| Q4 24 | 4.1% | 11.8% | ||
| Q3 24 | -0.6% | 4.6% | ||
| Q2 24 | -0.9% | — |
净利率AXGNRGS
| Q1 26 | -31.9% | — | ||
| Q4 25 | -22.0% | 0.8% | ||
| Q3 25 | 1.2% | 2.3% | ||
| Q2 25 | 1.0% | 192.9% | ||
| Q1 25 | -7.9% | 0.4% | ||
| Q4 24 | 0.9% | 16.4% | ||
| Q3 24 | -3.8% | -1.9% | ||
| Q2 24 | -4.0% | 184.7% |
每股收益（稀释后）AXGNRGS
| Q1 26 | $-0.38 | — | ||
| Q4 25 | $-0.28 | $0.16 | ||
| Q3 25 | $0.01 | $0.49 | ||
| Q2 25 | $0.01 | $43.67 | ||
| Q1 25 | $-0.08 | $0.08 | ||
| Q4 24 | $-0.00 | $2.71 | ||
| Q3 24 | $-0.04 | $-0.36 | ||
| Q2 24 | $-0.04 | $38.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.7M | $18.4M |
| 总债务越低越好 | — | $113.3M |
| 股东权益账面价值 | $244.8M | $188.7M |
| 总资产 | $289.5M | $588.3M |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资AXGNRGS
| Q1 26 | $82.7M | — | ||
| Q4 25 | $41.5M | $18.4M | ||
| Q3 25 | $35.8M | $16.6M | ||
| Q2 25 | $29.9M | $17.0M | ||
| Q1 25 | $22.1M | $13.3M | ||
| Q4 24 | $33.5M | $10.2M | ||
| Q3 24 | $24.5M | $6.3M | ||
| Q2 24 | $21.1M | $10.1M |
总债务AXGNRGS
| Q1 26 | — | — | ||
| Q4 25 | $48.4M | $113.3M | ||
| Q3 25 | $48.2M | $111.3M | ||
| Q2 25 | $47.9M | $110.8M | ||
| Q1 25 | $47.7M | $112.0M | ||
| Q4 24 | $47.5M | $111.5M | ||
| Q3 24 | $47.3M | $95.2M | ||
| Q2 24 | $47.0M | $99.5M |
股东权益AXGNRGS
| Q1 26 | $244.8M | — | ||
| Q4 25 | $128.8M | $188.7M | ||
| Q3 25 | $120.8M | $187.6M | ||
| Q2 25 | $112.3M | $185.6M | ||
| Q1 25 | $105.4M | $68.6M | ||
| Q4 24 | $103.9M | $66.7M | ||
| Q3 24 | $99.4M | $56.4M | ||
| Q2 24 | $95.7M | $56.8M |
总资产AXGNRGS
| Q1 26 | $289.5M | — | ||
| Q4 25 | $221.7M | $588.3M | ||
| Q3 25 | $216.4M | $592.1M | ||
| Q2 25 | $205.5M | $599.0M | ||
| Q1 25 | $196.2M | $511.2M | ||
| Q4 24 | $203.7M | $530.1M | ||
| Q3 24 | $192.0M | $508.9M | ||
| Q2 24 | $188.9M | $530.5M |
负债/权益比AXGNRGS
| Q1 26 | — | — | ||
| Q4 25 | 0.38× | 0.60× | ||
| Q3 25 | 0.40× | 0.59× | ||
| Q2 25 | 0.43× | 0.60× | ||
| Q1 25 | 0.45× | 1.63× | ||
| Q4 24 | 0.46× | 1.67× | ||
| Q3 24 | 0.48× | 1.69× | ||
| Q2 24 | 0.49× | 1.75× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $1.7M |
| 自由现金流经营现金流 - 资本支出 | $-1.4M | $891.0K |
| 自由现金流率自由现金流/营收 | -2.3% | 1.6% |
| 资本支出强度资本支出/营收 | — | 1.4% |
| 现金转化率经营现金流/净利润 | — | 3.65× |
| 过去12个月自由现金流最近4个季度 | $9.1M | $14.9M |
8季度趋势，按日历期对齐
经营现金流AXGNRGS
| Q1 26 | — | — | ||
| Q4 25 | $3.0M | $1.7M | ||
| Q3 25 | $3.2M | $2.3M | ||
| Q2 25 | $7.7M | $6.8M | ||
| Q1 25 | $-13.2M | $6.2M | ||
| Q4 24 | $8.7M | $2.1M | ||
| Q3 24 | $3.9M | $-1.3M | ||
| Q2 24 | $4.2M | $5.1M |
自由现金流AXGNRGS
| Q1 26 | $-1.4M | — | ||
| Q4 25 | $1.8M | $891.0K | ||
| Q3 25 | $1.7M | $1.9M | ||
| Q2 25 | $7.0M | $6.2M | ||
| Q1 25 | $-13.4M | $5.9M | ||
| Q4 24 | $8.1M | $1.7M | ||
| Q3 24 | $3.3M | $-1.4M | ||
| Q2 24 | $3.3M | $5.1M |
自由现金流率AXGNRGS
| Q1 26 | -2.3% | — | ||
| Q4 25 | 3.0% | 1.6% | ||
| Q3 25 | 2.8% | 3.2% | ||
| Q2 25 | 12.4% | 10.3% | ||
| Q1 25 | -27.7% | 10.3% | ||
| Q4 24 | 16.3% | 3.6% | ||
| Q3 24 | 6.8% | -3.0% | ||
| Q2 24 | 6.8% | 10.3% |
资本支出强度AXGNRGS
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | 1.4% | ||
| Q3 25 | 2.5% | 0.7% | ||
| Q2 25 | 1.3% | 0.9% | ||
| Q1 25 | 0.5% | 0.6% | ||
| Q4 24 | 1.4% | 0.9% | ||
| Q3 24 | 1.2% | 0.0% | ||
| Q2 24 | 1.9% | 0.0% |
现金转化率AXGNRGS
| Q1 26 | — | — | ||
| Q4 25 | — | 3.65× | ||
| Q3 25 | 4.55× | 1.68× | ||
| Q2 25 | 13.35× | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | 19.41× | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXGN
暂无分部数据
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
